Seed Biotech®

Allogeneic Solutions, in partnership with Seed Biotech®, offers aril® acellular allograft amniotic membrane. aril® is characterized and released through rigorous lot-to-lot bioanalytical testing.

Seed Biotech, Inc. is a Texas corporation based in Chattanooga, Tennessee, and a manufacturer of biologic products derived from human tissue. It is an FDA-registered human tissue establishment and an AATB-accredited tissue bank. aril® is processed by Seed Biotech as an acellular allograft amniotic membrane intended for homologous use under 21 CFR Part 1271 and Section 361 of the Public Health Service Act.

Seed Biotech designs its product lines around clinical convenience and practicality, from the packaging to the shape configurations. Products provided for distribution are verified against defined design and release requirements before they ship.

What sets Seed Biotech apart is its process. Their proprietary decellularization process demonstrates a greater than 95% reduction in DNA, measured lot to lot.

Seed Biotech's decellularization and stabilization process depletes cells and cellular content while preserving the extracellular matrix, including the basement membrane and its structural constituents. Processing is conducted in a quality-by-design facility under defined controls.

Our direct drop-ship relationship with Seed Biotech means clinicians receive product swiftly and reliably.